An investigational tetravalent meningococcal serogroups A, C, W-135 and Y-tetanus toxoid conjugate vaccine co-administered with Infanrix™ hexa is immunogenic, with an acceptable safety profile in 12–23-month-old children
Authors:
- Markus KnufMKMarkus Knuf
- Anna Pantazi-ChatzikonstantinouAPAnna Pantazi-Chatzikonstantinou
- Ulrich PfletschingerUPUlrich Pfletschinger
- Irmingard Tichmann-SchumannITIrmingard Tichmann-Schumann
- Hartwig MaurerHMHartwig Maurer
- Lothar MaurerLMLothar Maurer
- Thomas FischbachTFThomas Fischbach
- Henrike ZinkeHZHenrike Zinke
- Heidemarie Pankow-CulotHPHeidemarie Pankow-Culot
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Changes inNeisseria meningitidisDisease Epidemiology in the United States, 1998–2007: Implications for Prevention of Meningococcal DiseaseClinical Infectious Diseases, 2010
- Kinetics of Antibody Persistence following Administration of a Combination Meningococcal Serogroup C and Haemophilus influenzae Type b Conjugate Vaccine in Healthy Infants in the United Kingdom Primed with a Monovalent Meningococcal Serogroup C VaccineClinical and Vaccine Immunology, 2010
- Safety and immunogenicity of an investigational quadrivalent meningococcal conjugate vaccine after one or two doses given to infants and toddlersEuropean Journal of Clinical Microbiology & Infectious Diseases, 2009
- Global epidemiology of meningococcal diseaseVaccine, 2009
- Meningococcal A, C, Y and W-135 polysaccharide-protein conjugate vaccinesArchives of Disease in Childhood, 2007
- Validation of Serological Correlate of Protection for Meningococcal C Conjugate Vaccine by Using Efficacy Estimates from Postlicensure Surveillance in EnglandClinical and Vaccine Immunology, 2003
- Analysis ofNeisseria lactamicaantigens putatively implicated in acquisition of natural immunity toNeisseria meningitidisFEMS Immunology & Medical Microbiology, 2002
- Acellular pertussis vaccine in adults: Adverse reactions and immune responseEuropean Journal of Clinical Microbiology & Infectious Diseases, 1987
- Escherichia coli K51 and K93 capsular polysaccharides are crossreactive with the group A capsular polysaccharide of Neisseria meningitidis. Immunochemical, biological, and epidemiological studies.Journal of Experimental Medicine, 1985
- Cross-Antigenicity and Immunogenicity between Capsular Polysaccharides of Group C Neisseria meningitidis and of Escherichia coli K92The Journal of Infectious Diseases, 1977